Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | SPHK2 | Q9NRA0 | 4/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | CETP | P11597 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GMNN | O75496 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | CXCR5 | P32302 | 2/20 | 0.46 |
| ▸ | CCR6 | P51684 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | UBE2N | P61088 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30487053 | 1.00 | MEN1 (0.48) | MEN1KMT2ACYP3A4SPHK2SPHK1 | |
| SCHEMBL7590480 | 1.00 | MEN1 (0.48) | MEN1KMT2ACYP3A4SPHK2SPHK1 | |
| SCHEMBL9113984 | 0.91 | MEN1 (0.38) | MEN1KMT2ACYP3A4SPHK2SPHK1 | |
| SCHEMBL5815237 | 0.91 | MEN1 (0.38) | MEN1KMT2ACYP3A4SPHK2SPHK1 | |
| Acetic Acid SCHEMBL28405580 | 0.89 | ALDH1A1 (0.49) | MEN1KMT2ACYP3A4MAPTALDH1A1 | |
| SCHEMBL28636291 | 0.83 | FAAH (0.42) | MEN1KMT2ACYP3A4SPHK2SPHK1 | |
| SCHEMBL22207164 | 0.79 | MEN1 (0.50) | MEN1KMT2ACYP3A4SPHK2SPHK1 | |
| SCHEMBL29115796 | 0.79 | MEN1 (0.50) | MEN1KMT2ACYP3A4SPHK2SPHK1 | |
| SCHEMBL1200516 | 0.78 | MEN1 (0.44) | MEN1KMT2ACYP3A4SPHK2SPHK1 | |
| SCHEMBL5613339 | 0.75 | MEN1 (0.53) | MEN1KMT2ACYP3A4SPHK2SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118048210-B | Detergent composition | 广州立白企业集团有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118048210-A | Detergent composition | 广州立白企业集团有限公司 | 2024-05-17 | — | — | CN | disclosed |
| US-20230416185-A1 | NEW METHODS FOR DISPROPORTIONATION QUENCHING OF OZONIDES | P2 SCIENCE, INC. | 2023-12-28 | — | — | US | disclosed |
| US-11814350-B2 | Methods for disproportionation quenching of ozonides | P2 SCIENCE, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| EP-1195099-B1 | Deodorant composition and its application | TAKASAGO PERFUMERY CO LTD (JP) | 2017-03-15 | — | — | EP | disclosed |
| EP-1195099-A2 | Deodorant composition and its application | Takasago International Corporation (JP) | 2002-04-10 | — | — | EP | disclosed |
| US-3962321-A | ADDING A PYRAZINE AND 2-NONENAL ANDOR 2-NONENOL | GENERAL FOODS CORPORATION (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814350-B2 | Methods for disproportionation quenching of ozonides | ALKBH3, ALKBH2, CYP11B2 | MEN1 3206/4885KMT2A 3153/4885CYP3A4 262/4885 |
| US-20230416185-A1 | NEW METHODS FOR DISPROPORTIONATION QUENCHING OF OZONIDES | ALKBH3, ALKBH2, NOX3 | MEN1 3622/4885KMT2A 3315/4885CYP3A4 415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.